Lantern Pharma Announces Two Presentations at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting
DALLAS, June 17, 2020 (GLOBE NEWSWIRE) — Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company focused on leveraging artificial […]